2016-2026年呼吸系統領域的合作與授權協議

Respiratory Collaboration and Licensing Deals 2016-2026

出版日期: 2026年10月01日 | 出版商:

Current Partnering | 英文 250+ Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

利用 464 個真實合作和許可交易的信息，了解呼吸系統合作格局。

「2016-2026 年呼吸系統合作與許可交易」提供了有關呼吸系統領域資產、技術和開發計劃的 464 項合作交易的全面資訊。

呼吸系統領域的合作涵蓋了各種急性和慢性疾病，交易結構反映了生物製藥、吸入療法、標靶治療和新興技術的創新，以及已確立的治療方法。

本報告將這些趨勢匯總到一個資源中，使用戶能夠了解哪些公司正在合作，哪些呼吸系統機會正在吸引關注，交易是如何構建的，披露了哪些財務條款，以及交易如何因適應症、技術和開發階段而異。

這份報告不只是簡單地列出了交易清單；它結合了全面的市場交易分析和財務基準、主要交易者的信息、詳細的交易記錄，以及在有公開合約文件的情況下對其進行訪問。

本報告為呼吸系統領域的業務發展、許可、研究和評估、公司策略、研發策略、競爭情報分析以及參與合作的法律團隊提供可操作的資訊和基準資源。

了解呼吸領域合作趨勢。

本報告分析了2016年至2026年呼吸系統領域的交易情況，內容包括：

呼吸領域合作的年度趨勢
按交易類型分類的交易趨勢
產業部門
合作關係發展階段
技術類型
適應症
呼吸領域最活躍的交易商
根據已披露的交易金額，主要交易
呼吸領域合作活動的趨勢
這使用戶能夠確定活動集中在哪裡，並了解哪些公司、技術、開發階段和呼吸系統疾病適應症吸引了合作興趣。
呼吸領域合夥企業的財務狀況基準分析
財務條款可能因資產、開發階段、技術、授予的權利以及交易的整體結構而有很大差異。

本報告對已揭露的財務狀況進行了詳細分析，包括以下幾點：

交易總額
預付款
里程碑付款
版稅率
透過分析這些基準背後的具體交易，用戶可以更全面地了解所揭露的經濟數據背後的經濟狀況。
這為內部基準測試、機會評估、交易準備和談判提供了一個現實的基準。
財務基準只有在結合類似交易的結構和情況進行解讀時才最有用，而不僅僅是作為平均值來解讀。本報告提供了建立這種背景所需的基礎交易資訊。
確定呼吸系統領域的關鍵交易商和潛在的未來夥伴。
該報告列出了在呼吸系統領域合作活動最活躍的公司，並提供了交易歷史記錄，以便用戶可以調查這些公司過去的活動。

這有助於用戶識別以下內容：

積極尋求呼吸領域機會的公司
有前景的許可和合作研究夥伴
我們曾多次與相關組織就相關呼吸系統疾病的適應症進行合作。
積極參與開發過程的公司
對特定技術、模式或治療方法感興趣的交易商
競爭對手正在推廣相關的外部創新策略
對於尋求呼吸系統資產和技術合作夥伴的公司而言，過去的交易歷史可以提供寶貴的見解，了解哪些組織對類似的機會表現出了興趣。
比較針對不同呼吸系統疾病適應症和標靶的合作活動。
呼吸系統疾病涵蓋範圍廣泛，包括各種急性和慢性疾病、生物標的和治療方法，每種都有其獨特的科學、臨床和商業性趨勢。
本報告按治療適應症和治療標靶分析合作趨勢，使用戶能夠專注於與特定項目和策略關注事項最相關的交易，而不是僅依賴呼吸系統領域的廣泛基準。
結合技術和發展階段的分析，用戶可以發現更多有意義的類似交易和潛在的未來合作關係。
了解呼吸領域合約的結構
本報告涵蓋合作、授權、開發、研發及其他合作交易。

根據交易詳情和資訊披露，用戶可以調查以下方面：

授予和保留的權利
負責研發工作
授權權
獨家版權
區域權利
智慧財產
發展和監管義務
負責生產和供應
商業化權利
金錢補償
里程碑和版稅
管治
合約期限和終止條款
這些例子為考慮呼吸領域合作的適當框架提供了寶貴的見解。
從實際合約文件中學習
本報告在公開可取得的情況下，提供了與選定的呼吸系統產業交易相關的基礎合約文件的存取權限。

這些合約提供的資訊遠比簡單的標題公告所能展現的要詳細得多，使用戶能夠檢驗公司如何記錄諸如以下事項：

權利範圍
發展義務
智慧財產
獨家版權
財務狀況
里程碑觸發條件
特許權使用費規定
商業化權利
合約終止及其他談判事項
對於準備和談判呼吸領域合作與許可協議的團隊來說，獲取實際的合約措辭可以讓他們深入了解類似交易在實踐中的結構。
呼吸領域綜合貿易目錄
本報告包含呼吸領域 464 項合作與授權協議的綜合目錄，可作為識別相關領先的專業資訊來源。

在以下條件下可以查看交易記錄：

公司
技術類型
治療適應症或標靶
合約揭露狀態
每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊和相關的合約文件（如有）。
誰該使用這份報告？
業務拓展與授權團隊
識別類似的呼吸系統相關交易、潛在合作夥伴和相關交易結構。
研究與評估團隊
我們尋找那些在相關適應症、技術、目標和開發階段積極探索呼吸系統領域商機的公司。
尋求合作夥伴的生技公司
找出對類似呼吸系統資產或技術表現出明確興趣的組織。
企業策略與研發策略團隊
我們將了解我們的競爭對手和潛在合作夥伴如何透過外部創新來建立其呼吸系統產品組合。
競爭與市場情報團隊
按公司、適應症、目標、開發階段和技術追蹤合作趨勢，以了解不斷變化的策略重點。
法律及交易團隊
我們將仔細審查公開的合約和以往的合約結構，以幫助您準備和談判交易。
我們將整個呼吸系統市場的訊息轉化為針對特定公司的洞察。
對於符合資格的客戶，Current Partnering 不僅會提供報告，還會為高階主管提供客製化的合作關係簡報。
本簡報將為您提供呼吸領域交易的基本信息，並根據您自己的資產、技術、適應症、目標或合作目標量身定做。
如有需要，我們可以提供相關的類似交易、有前景的合作夥伴、競爭對手的活動、發展階段分析、交易結構、財務基準、忠誠度分析、合約見解以及其他專門為您選擇的資訊。
請索取樣本或聯絡 Current Partnering 討論報告內容以及我們是否可以為貴公司提供客製化分析。

The report brings this activity together in one resource, enabling users to understand who is partnering, which respiratory opportunities are attracting interest, how transactions are structured, what financial terms have been disclosed and how dealmaking differs across therapeutic indications, technologies and stages of development.

Rather than simply providing a list of transactions, the report combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.

It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, corporate strategy, R&D strategy, competitive intelligence and legal teams involved in respiratory partnering.

Understand the respiratory partnering landscape

The report analyzes respiratory dealmaking from 2016 to 2026, including:

Trends in respiratory partnering by year
Deal activity by deal type
Industry sector
Stage of development at the time of partnering
Technology type
Therapeutic indication
Most active respiratory dealmakers
Leading deals by disclosed value
How respiratory partnering activity is evolving
This enables users to identify where activity is concentrated and understand which companies, technologies, development stages and respiratory indications are attracting partnering interest.
Benchmark respiratory deal financials
Financial terms can vary considerably according to the asset, development stage, technology, rights granted and overall transaction structure.

The report provides dedicated analysis of disclosed financial terms, including:

Headline deal values
Upfront payments
Milestone payments
Royalty rates
Users can investigate the individual transactions behind these benchmarks to understand the wider context surrounding the disclosed economics.
This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
Financial benchmarks are most useful when interpreted alongside the structure and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
Identify leading respiratory dealmakers and prospective partners
The report identifies the most active companies in respiratory partnering and provides transaction histories that enable users to investigate their previous activity.

This can help users identify:

Companies actively seeking respiratory opportunities
Prospective licensing and collaboration partners
Organizations repeatedly partnering in relevant respiratory indications
Companies active at relevant stages of development
Dealmakers demonstrating interest in particular technologies, modalities or therapeutic approaches
Competitors pursuing related external innovation strategies
For companies seeking to partner a respiratory asset or technology, previous transaction activity can provide useful evidence of which organizations have demonstrated an appetite for comparable opportunities.
Compare partnering activity across respiratory indications and targets
Respiratory disease encompasses a range of acute and chronic conditions, biological targets and treatment approaches with differing scientific, clinical and commercial dynamics.
The report analyzes partnering by therapeutic indication and therapeutic target, enabling users to move beyond broad respiratory benchmarks and focus on transactions most relevant to a particular program or strategic interest.
Combined with analysis by technology and development stage, this helps users identify more meaningful comparable transactions and prospective partners.
Understand how respiratory agreements are structured
The report includes collaboration, licensing, development, research and other partnering transactions.

Depending on the transaction and available disclosure, users can investigate areas including:

Rights granted and retained
Research and development responsibilities
Licensing rights
Exclusivity
Geographic rights
Intellectual property
Development and regulatory obligations
Manufacturing and supply responsibilities
Commercialization rights
Financial consideration
Milestones and royalties
Governance
Term and termination provisions
These real-world examples provide useful reference points when considering the appropriate structure for a respiratory partnership.
Learn from real-world contract documents
Where publicly available, the report provides access to underlying contract documents for selected respiratory transactions.

These agreements can provide substantially more detail than headline announcements alone, enabling users to examine how companies have documented areas such as:

Scope of rights
Development obligations
Intellectual property
Exclusivity
Financial terms
Milestone triggers
Royalty provisions
Commercialization rights
Termination and other negotiated provisions
For teams preparing or negotiating a respiratory collaboration or licensing agreement, access to real contract language provides valuable insight into how comparable deals have been structured in practice.
Comprehensive respiratory deal directory
The report includes a comprehensive directory of 464 respiratory collaboration and licensing deals, providing a focused resource for identifying relevant precedent transactions.

Deals can be reviewed by:

Company
Technology type
Therapeutic indication or target
Contract availability
Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
Who should use this report?
Business Development and Licensing teams
Identify comparable respiratory transactions, prospective partners and relevant deal structures.
Search and Evaluation teams
Understand which companies are actively seeking respiratory opportunities across relevant indications, technologies, targets and development stages.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated interest in comparable respiratory assets and technologies.
Corporate and R&D Strategy teams
Understand how competitors and prospective partners are building respiratory portfolios through external innovation.
Competitive and Market Intelligence teams
Track partnering activity by company, indication, target, development stage and technology to understand evolving strategic priorities.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
Turn market-wide respiratory intelligence into company-specific insight
For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
The briefing applies the underlying respiratory deal intelligence to the customer's own asset, technology, indication, target or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, deal structures, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.